FABP4 and nephrotic syndrome: Since levels of P-FABP4 were comparable in MCNS and MN in patients with nephrotic syndrome (Supplementary Fig. S1), the difference in U-FABP4 between the two groups would be attributable to new expression of FABP4 in the kidney.